The Discounted Cash Flow (DCF) valuation of Karuna Therapeutics Inc (KRTX) is (712.69) USD. With the latest stock price at 329.83 USD, the upside of Karuna Therapeutics Inc based on DCF is -316.1%.
Based on the latest price of 329.83 USD and our DCF valuation, Karuna Therapeutics Inc (KRTX) is a sell. selling KRTX stocks now will result in a potential gain of 316.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.3% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.9% | 4.0% |
| Fair Price | (4,810.12) - (397.54) | (712.69) |
| Upside | -1558.4% - -220.5% | -316.1% |